Salesforce
CRM
$230.90
-4.63%
Salesforce, Inc. is the world's leading enterprise cloud software company, delivering Customer Relationship Management (CRM) technology through its Customer 360 platform, which unifies sales, service, marketing, commerce, and data integration (MuleSoft) capabilities across systems, apps, and devices. The company is the dominant platform incumbent in the $200B+ enterprise applications market, distinguished by its ecosystem scale, 83,334 employees, and a land-and-expand subscription model that generates roughly 95% recurring revenue (Subscription and Support contributed $10.82B of the $11.345B most recent quarter). The current investor narrative centers on three intertwined debates: whether Salesforce can defend its CRM franchise against AI-native disruptors (a threat partially neutralized by its new partnership with Anthropic), whether its aggressive capital return program — highlighted by Marc Benioff's roughly $25 billion buyback bet against the 'SaaSpocalypse' — can re-rate a stock that has de-rated to mid-teens forward earnings, and whether the recently announced all-cash acquisition of Braze at $47.50 per share can extend its customer engagement and marketing reach without introducing integration risk. With the stock up roughly 52% over three months but still down about 2.5% over the trailing year, investors are actively debating whether this is the start of a durable AI-driven re-rating or a sharp mean-reversion rally within a longer downtrend.…
CRM
Salesforce
$230.90
Related headlines
Investment Opinion: Should I buy CRM Today?
The synthesized recommendation is Buy, anchored by the analyst consensus rating of 'buy' (mean 1.70) and an average target price of $286.14, which implies 15.1% upside from the current price of $248.57. The core thesis is that Salesforce is undervalued at 15.5x forward earnings, with a massive $25 billion buyback program and a strategic AI partnership that positions it for a re-rating as growth stabilizes. Supporting evidence includes a forward P/E of 15.52x, which is well below the software sector average; revenue growth of 10.83% YoY; a net margin of 17.96% and operating margin of 21.47%; free cash flow of $15.15 billion TTM; and a PEG ratio of 1.24, suggesting the stock is reasonably priced relative to growth. The 15.1% upside to the average analyst target further supports the buy case. Key risks that could invalidate the thesis include a failure to integrate Braze, a re-acceleration of AI-driven competition, and a broader market downturn that compresses multiples. The rating would upgrade to a strong buy if revenue growth accelerates above 15% or if the stock pulls back below $200, and it would downgrade to Hold if growth decelerates below 8% or if operating margins fall below 18%. Relative to its history and peers, Salesforce appears undervalued, trading at a discount to its historical P/E and with a PEG ratio near 1.2, making it an attractive value play in the software space.
Sign up to view all
CRM 12-Month Price Forecast
The forward-looking view is bullish, driven by Salesforce's attractive valuation, strong cash flow generation, and strategic AI partnership that mitigates disruption risk. While revenue growth has decelerated, the company's recurring revenue model and margin expansion provide a solid foundation. The Braze acquisition adds growth potential but carries integration risk. The analyst consensus and buyback program offer support. I would upgrade to high confidence if revenue growth re-accelerates above 12% or if AI products gain significant traction; I would downgrade to neutral if growth falls below 8% or if margins contract.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $287.08 and implied upside of +24.3% versus the current price.
Average Target
$287.08
0 analysts
Implied Upside
+24.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$165 - $475
Analyst target range
Bulls vs Bears: CRM Investment Factors
The bull case for Salesforce rests on its attractive valuation (15.5x forward earnings), massive buyback program, strong free cash flow, and the strategic Anthropic partnership that mitigates AI disruption risk. The bear case highlights decelerating revenue growth (10.8% YoY), integration risks from the Braze acquisition, and relative underperformance versus the market. Currently, the bull evidence appears stronger given the stock's 51.9% three-month rally, analyst consensus 'buy' rating, and the 15.1% upside to the average target price. The most critical tension is whether Salesforce can re-accelerate growth through AI innovation and acquisitions, or whether it will remain a low-growth, value-oriented software play. Resolution of this debate will likely determine the stock's trajectory over the next 12 months.
Bullish
- Massive buyback and capital return: Marc Benioff's roughly $25 billion buyback program has reduced shares outstanding from 974 million diluted in Q4 FY2025 to 821 million in Q2 FY2027, a 15.7% reduction. This capital return, combined with a modest 0.79% dividend yield, signals management's conviction that the stock is undervalued and provides a strong floor for the share price.
- AI threat neutralized via Anthropic partnership: Salesforce's partnership with Anthropic removes a major AI disruption threat and opens a significant upsell opportunity, as noted in recent news. This strategic move positions Salesforce to integrate advanced AI into its Customer 360 platform, potentially accelerating growth and defending its CRM franchise against AI-native competitors.
- Attractive valuation at 15.5x forward earnings: The stock trades at a forward P/E of 15.52x, a steep discount to its historical multiples and well below the broader software sector. With a PEG ratio of 1.24 and EV/EBITDA of 16.1x, the valuation appears compelling given the company's 10.8% revenue growth and 21.5% operating margin.
- Strong profitability and cash flow: Salesforce generated $15.15 billion in trailing twelve-month free cash flow and a net margin of 17.96%, with operating margin at 21.47%. The company's subscription model yields roughly 95% recurring revenue, providing high earnings visibility and resilience.
Bearish
- Revenue growth decelerating: Revenue growth has slowed to 10.83% year-over-year in Q2 FY2027, down from higher rates in prior years. This deceleration raises concerns about market saturation and intensifying competition, particularly from AI-native CRM solutions and peers like Veeva, which recently raised its FY27 outlook.
- Integration risk from Braze acquisition: The all-cash acquisition of Braze at $47.50 per share could introduce integration challenges and distract management. As noted in recent news, the deal turns Braze into a low-return arbitrage play, and Salesforce investors should watch for integration risks and strategic fit.
- Relative underperformance vs. market: Despite a 51.9% rally over the past three months, the stock is still down 2.54% over the trailing year and has underperformed the S&P 500 by 15.67 percentage points. This relative weakness suggests lingering skepticism about the durability of the rally.
- High beta and volatility: With a beta of 1.256, Salesforce is more volatile than the market, and its max drawdown of -43.61% over the past year illustrates significant downside risk. The stock's 52-week range of $146.32 to $269.11 reflects wide price swings that could continue.
CRM Technical Analysis
Beta
1.26
1.26x market volatility
Max Drawdown
-43.6%
Largest decline past year
52-Week Range
$146-$269
Price range past year
Annual Return
-8.2%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | +2.5% | +0.7% |
| 3m | +25.5% | +3.0% |
| 6m | +25.6% | +6.8% |
| 1y | -8.2% | +11.9% |
| ytd | -9.0% | +12.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Quarterly Revenue
$11.3B
2026-07
Revenue YoY Growth
+10.8%
YoY Comparison
Gross Margin
76.6%
Latest Quarter
Free Cash Flow
$15.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
PE
27.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~247x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on Salesforce's decelerating revenue growth, which slowed to 10.83% year-over-year in Q2 FY2027, and the company's ability to integrate acquisitions like Braze without disrupting margins. The current ratio of 0.76 suggests potential liquidity tightness, though strong free cash flow of $15.15 billion TTM mitigates immediate concerns. Additionally, the company's reliance on subscription revenue (95% recurring) provides stability but also limits upside from transactional or usage-based models. Margin pressure could emerge if integration costs rise or if AI investments require higher operating expenses; operating margin currently stands at 21.47%, but any decline could weigh on earnings. Market and competitive risks include the threat of AI-native CRM disruptors, although the Anthropic partnership partially addresses this. Salesforce's beta of 1.256 indicates it is more volatile than the market, and with a forward P/E of 15.52x, the stock is not immune to valuation compression if growth fails to accelerate. Competitive pressures from peers like Veeva, which raised its FY27 outlook, and the risk of sector rotation away from software could limit upside. The Braze acquisition, while strategic, introduces execution risk and could distract management from core innovation. In a worst-case scenario, a combination of slowing growth, integration missteps, and a broader market downturn could drive the stock toward its 52-week low of $146.32, representing a 41.1% decline from the current price of $248.57. The analyst low target of $165 implies a 33.6% downside, and the max drawdown of -43.61% over the past year underscores the potential severity of a sell-off. Such a scenario could be triggered by a significant earnings miss, loss of a major customer, or failure of the AI strategy to gain traction.
FAQ
The key risks include: 1) Financial risk from decelerating revenue growth (10.83% YoY) and potential margin pressure, with a current ratio of 0.76 indicating tight liquidity. 2) Competitive risk from AI-native CRM disruptors and peers like Veeva, which recently raised its FY27 outlook. 3) Integration risk from the Braze acquisition, which could distract management and lead to writedowns. 4) Macro risk, as a beta of 1.256 means the stock is more volatile than the market, and a downturn could compress multiples. The most severe risk is a growth stall that could drive the stock toward its 52-week low of $146.32.
Our 12-month forecast has three scenarios: Bull case (30% probability) with a target range of $286-$475, driven by successful AI integration and re-accelerated growth; Base case (50% probability) with a target range of $250-$286, assuming steady 10-11% growth and margin stability; Bear case (20% probability) with a target range of $146-$165, reflecting growth deceleration and integration missteps. The base case is most likely, hinging on Salesforce maintaining its current growth trajectory and executing on its buyback and AI strategy. The average analyst target of $286.14 aligns with our base case.
CRM appears undervalued based on its forward P/E of 15.52x, which is well below the software sector average and its own historical multiples. The PEG ratio of 1.24 suggests the stock is reasonably priced relative to its growth rate, while the EV/EBITDA of 16.1x is moderate. The market is pricing in modest growth expectations of around 10%, but if Salesforce can accelerate growth through AI and acquisitions, there is potential for multiple expansion. Compared to peers, CRM trades at a discount, making it an attractive value play in the software space.
From a risk/reward perspective, CRM appears attractive for value-oriented investors. The stock trades at 15.5x forward earnings, a discount to its historical average, with a 15.1% upside to the analyst average target of $286.14. The biggest downside risk is a growth deceleration that could push the stock toward its 52-week low of $146.32, representing a 41% decline. However, the $25 billion buyback and strong free cash flow provide a margin of safety. For long-term investors comfortable with moderate volatility (beta 1.256), CRM is a good buy at current levels, but short-term traders should be cautious given the recent 51.9% rally and potential for consolidation.
CRM is more suitable for long-term investment (minimum 2-3 years) given its recurring revenue model, strong free cash flow, and ongoing transformation. The stock's beta of 1.256 and max drawdown of -43.61% indicate significant volatility, making it less ideal for short-term trading. The 0.79% dividend yield and $25 billion buyback provide income and support, but the real upside comes from AI-driven growth and multiple expansion over time. Short-term traders could capitalize on momentum, but the recent 51.9% rally suggests caution. A holding period of at least 2-3 years allows time for the Braze integration and AI initiatives to bear fruit.